NHS Digital Data Release Register - reformatted

Wolfson Institute of Preventive Medicine

Opt outs honoured: Y

Basis: Section 251 approval is in place for the flow of identifiable data

Format: Identifiable Sensitive

How often: Ongoing

When: unknown — 11/2016

HSCIC Id: DARS-NIC-148484-PSL6Q-v0.0

Data: MRIS - Cause of Death Report

Data: MRIS - Cause of Death Report

Data: MRIS - Cause of Death Report

Data: MRIS - Cohort Event Notification Report

Data: MRIS - Cohort Event Notification Report

Data: MRIS - Scottish NHS / Registration

Data: MRIS - Cohort Event Notification Report

Data: MRIS - Scottish NHS / Registration

Data: MRIS - Cause of Death Report

Data: MRIS - Cohort Event Notification Report

Data: MRIS - Scottish NHS / Registration

Data: MRIS - Cause of Death Report

Data: MRIS - Cohort Event Notification Report

Data: MRIS - Scottish NHS / Registration

Project info


Objective: The aim of this study is to determine the effect on mortality from breast cancer of mammographic screening in women starting ages 40-41, compared with starting at age 50 as in the current national breast cancers diagnosed in the trial population to predict outcomes. Data Access is restricted to those names in section 7 of this agreement. Any changes will be notified to the HSCIC


Objective: 1) To carry out a prospective epidemiological study of the association between carboxyhaemoglobin COHG levels and motality from lung cancer and ischaemic heart disease (IHD). 2) To inestigate the interrelationships of COHG levels with risk factor of IHD and estimate their value in predicting IHD.


Objective: To determine the value of preventive angioplasty (a procedure in which fine balloons are positioned and expanded within coronary arteries) to dilate all identified significantly narrowed coronary arteries among patients having therapeutic angioplasty to treat a myocardial infarction; ie angioplasty limited to unblocking the artery causing the myocardial infarction. The primary aim is to determine whether preventive angioplasty undertaken at the time of treating the artery responsible for the myocardial infarction reduces the incidence of the combined endpoint of coronary death, nonāˆ’fatal myocardial infarction and refractory angina. The secondary aims are: 1. To determine and quantify the safety of preventive angioplasty among patients undergoing therapeutic angioplasty for an acute myocardial infarction. 2. To undertake an economic evaluation comparing the cost to the NHS of preventive PCI. 3. To undertake a quality of life assessment in patients randomised to each treatment strategy.


Objective: The data supplied by the HSCIC to Wolfson Institute of Preventive Medicine will be used only for the approved medical research project - MR170 Women with Benign Breast Disease



Source: NHS Digital.